The Wall Street Journal - Markets Chip Gear Makers Perfect the Earnings Machine 2017-08-22T11:41:43.000000000-04:00 Makers of semiconductor manufacturing equipment are more profitable than ever, which poses an interesting dilemma for investors accustomed to buying low and selling high. The Price Isn't Right for Home Builders 2017-08-22T10:13:21.000000000-04:00 Shares of home builders look pricey and vulnerable to a correction as costs rise and affordability is strained. Why the ECB Can't Catch a Break on the Euro 2017-08-22T09:50:20.000000000-04:00 At the start of July, both German bond yields and the euro were moving higher. But in August they have diverged, with bond yields off the boil but the euro maintaining its poise. The answer to the conundrum may lie outside the eurozone. Free Money From a Smart Insurer 2017-08-22T09:19:27.000000000-04:00 Talk of a breakup of U.K. insurer Prudential returns as regularly as summer holidays. A nuanced view of the company’s plans promises value to investors. BHP Rights Its Ship by Throwing Shale Overboard 2017-08-22T03:31:59.000000000-04:00 Following an intense pressure campaign from shareholder Elliott Management, BHP has announced it is looking to exit U.S. shale. Why Monetary Policy Isn't the Only Game in Town Anymore 2017-08-21T16:23:42.000000000-04:00 The Jackson Hole gathering of central bankers has been an opportunity for policy makers to pledge extraordinary support for economies, in particular via quantitative easing. But this year looks different. Virtual Reality's Real Sticker Shock 2017-08-21T12:49:34.000000000-04:00 High-end virtual reality headsets are getting a little cheaper with price cuts by Oculus and now HTC. But compelling games still needed to make a sustainable business. Smaller Firms Are Winning the Deals 2017-08-21T06:15:11.000000000-04:00 Merger and acquisition activity is retreating, but some boutique investment banks are still raking in fees. Low Price Is the Only Winner in Retail 2017-08-18T18:29:08.000000000-04:00 It might seem like the most basic retail maxim, but the second-quarter drilled it home for investors: low prices matter. The only winners in an otherwise bleak retail landscape were the ones offering the lowest ones. Biogen Treads Tricky Path Between Politicians, Investors 2017-08-18T18:24:25.000000000-04:00 Biogen is taking a political risk with aggressive multiple sclerosis drug pricing, but the company is under pressure to boost its share price.